Key statistics
As of last trade Xenon Pharmaceuticals Inc (XP0:BER) traded at 39.60, -15.02% below its 52-week high of 46.60, set on Feb 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 39.80 |
---|---|
High | 39.80 |
Low | 39.60 |
Bid | 39.20 |
Offer | 40.20 |
Previous close | 39.60 |
Average volume | 31.89 |
---|---|
Shares outstanding | 76.24m |
Free float | 75.43m |
P/E (TTM) | -- |
Market cap | 3.14bn USD |
EPS (TTM) | -2.81 USD |
Data delayed at least 15 minutes, as of Nov 26 2024 13:10 GMT.
More ▼
Announcements
- Xenon to Showcase New Long-Term Azetukalner Data at AES 2024
- Xenon to Present at Upcoming Investor Conferences
- Xenon Reports Q3 2024 Financial Results and Business Update
- Xenon to Report Q3 2024 Financial Results on November 12, 2024
- Xenon to Present at BofA Securities 2024 CNS Therapeutics Virtual Conference
- Xenon Showcases Azetukalner Data at 15th European Epilepsy Congress
- Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer
- Xenon Reports Q2 2024 Financial Results and Business Update
- Xenon to Report Q2 2024 Financial Results on August 8, 2024
- Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
More ▼